OPEN END TURBO PUT-OPTIONSSCHEIN MIT SL - MERCK & CO. | Market Closed - Boerse Frankfurt Warrants 20:45:21 21/05/2024 BST | ||
| 3.15 EUR | +1.29% |
|
| Current month | -6.01% | ||
| 1 month | -14.01% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 21/05/24 | 3.13 | +0.64% |
| 20/05/24 | 3.11 | -0.64% |
| 17/05/24 | 3.13 | +0.32% |
| 16/05/24 | 3.12 | +1.96% |
| 15/05/24 | 3.06 | -8.11% |
Real-time Boerse Frankfurt Warrants
Last update May 21, 2024 at 08:45 pm
More quotesStatic data
| Product type | Knock-Out mit Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | MERCK & CO., INC. |
| Issuer | 
Société Générale
|
| WKN | SU7VFW |
| ISIN | DE000SU7VFW7 |
| Date issued | 05/02/2024 |
| Strike | 164.9 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 3.65 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.11 € |
|---|---|
| Lowest since issue | 2.9 € |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.8
USD
Average target price
141.6
USD
Spread / Average Target
+8.32%
- Stock Market
- Certificates
- Certificat
